RETRACTION: Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer (Retraction of Vol 53, Pg 1013, 2018)

被引：1

|

作者：

Dong, Huaying

Wang, Wei

Chen, Ru

Zhang, Yu

Zou, Kejian

Ye, Mulin

He, Xionghui

Zhang, Fan

Han, Jing

机构：

来源：

INTERNATIONAL JOURNAL OF ONCOLOGY | 2022年 / 61卷 / 02期

关键词：

D O I：

10.3892/ijo.2022.5382

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页数：1

相关论文

共 42 条

[31] RETRACTION: MiR-320d suppresses the progression of breast cancer via lncRNA HNF1A-AS1 regulation and SOX4 inhibition (Retraction of Vol 8, Pg 19196, 2018)
Shi, Shuai
Hu, Xiaoling
Xu, Jianpo
Liu, Hong
Zou, Libo
RSC ADVANCES, 2022, 12 (41) : 26639 - 26639
[32] RETRACTION: LncRNA AWPPH promotes the growth of triple-negative breast cancer by up-regulating frizzled homolog 7 (FZD7) (Retraction of Vol 38, art no BSR20181223, 2018)
Cooper, Christopher D. O.
BIOSCIENCE REPORTS, 2022, 42 (05)
[33] RETRACTION: LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer (Retraction of Vol 7, Pg 842, 2018)
Zhao, W.
Geng, D.
Li, S.
Chen, Z.
Sun, M.
CANCER MEDICINE, 2023, 12 (24): : 22437 - 22437
[34] RETRACTION: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer (Retraction of Vol 18, art no 3, 2019)
Dong, Huaying
Hu, Jianguo
Zou, Kejian
Ye, Mulin
Chen, Yuanwen
Wu, Chengyi
Chen, Xin
Han, Mingli
MOLECULAR CANCER, 2022, 21 (01)
[35] RETRACTION: MicroRNA-511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway (Retraction of Vol 53, Pg 2715, 2018)
Zhao, Yuying
Pang, Weifeng
Yang, Ning
Hao, Ling
Wang, Lei
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 61 (04)
[36] RETRACTION: Aromatase Inhibitor-mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer (Retraction of Vol 14, Pg 1728, 2015)
Khatri, Raju
Shah, Preeti
Guha, Rupa
Rassool, Feyruz V.
Tomkinson, Alan E.
Brodie, Angela
Jaiswal, Anil K.
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (11) : 2491 - 2491
[37] RETRACTION: Cost-utility analysis of trastuzumab combined with Docetaxel for patients with HER-2 positive metastatic breast cancer - real world claim data (Retraction of Vol 24, Pg 7P2, 2018)
不详
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : NP1 - NP1
[38] RETRACTION: ILF3-AS1 promotes cell proliferation and inhibits cell apoptosis of breast cancer by binding with miR-4429 to upregulate RAB14 (Retraction of Vol 40, Pg 1183, 2021)
Zhang, X.
Xie, X.
Gao, K.
Wu, X.
Chen, Y.
Yu, T.
HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
[39] RETRACTION: ILF3-AS1 promotes cell proliferation and inhibits cell apoptosis of breast cancer by binding with miR-4429 to upregulate RAB14 (Retraction of Vol 40, Pg 1183, 2021)
Zhang, X.
Xie, X.
Gao, K.
Wu, X.
Chen, Y.
Yu, T.
HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
[40] RETRACTION: MicroRNA-92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer (Retraction of Vol 7, Pg 3118, 2018)
Li, Zeng-Hui
Li, Lei
Kang, Lin-Ping
Wang, Yan
CANCER MEDICINE, 2021, 10 (20): : 7440 - 7440

← 1 2 3 4 5 →